How Ivermectin Trials Were Designed to Fail
Despite the proven efficacy of ivermectin in treating COVID-19, some studies in top-tier journals have concluded otherwise. Which data should we trust?

By Yuhong Dong, M.D., Ph.D.
4/10/2024
Updated: 5/4/2024


The use of ivermectin to treat COVID-19 is an ongoing debate. The central conflict is that although many doctors have reported success in using ivermectin, some studies published in major journals suggest it is in fact ineffective.

Even as the FDA recently has been removing misinformation it posted about ivermectin, the agency has maintained its original position regarding its effectiveness, namely that there isn’t evidence.

People who trust ivermectin claim that the studies showing ineffectiveness are fraudulent, while people who are skeptical of its use for treating COVID-19 view that as an anti-science conspiracy theory.

As a professional with decades of research experience conducting dozens of clinical trials on antiviral drugs, I decided to dive deep into the studies purporting ivermectin’s ineffectiveness.

What I found shocked me.

Legacy Media Report Ineffectiveness

Numerous preclinical studies have found that ivermectin has a broad range of effects on COVID-19, spanning from its initial effect on viral infection to its effect on the pathological changes the virus causes in our bodies.

Ivermectin inhibits the entire life cycle of SARS-CoV-2 in our cells, including attachment, spreading, and replication (1, 2, 3).

Moreover, ivermectin is anti-inflammatory and organ-protective, which can potentially protect against severe COVID-related lung damage and acute respiratory distress syndrome, heart-related complications, and blood clots.

Ivermectin exceeds the approved antiviral effects of other medications-- excerpt, rest at link above --